Hard-to-heal wounds benefit from MatriStem

PARTICIPANTS in a study whose wounds were treated with MatriStem medical devices showed a decrease in mean closure time of wounds compared to those that received previous applications of other advanced wound care products.

Analysis showed all wounds utilizing MatriStem, the only commercially available form of urinary bladder matrix (UBM), achieved complete closure including those with exposed bone, tendon, and joint closure in the 34-patient study.

The medical devices were featured in a peer-reviewed article, "Porcine Urinary Bladder matrix: a Retrospective Study and Establishment of Protocol," published in the October, 2012 issue of the Journal of Wound Care.  In the study MatriStem was shown to be a novel advanced wound care modality in the treatment of complex lower extremity diabetic, venous insufficient, ischemic and decubitus ulcers.

MatriStem medical devices from ACell are porcine-derived extracellular matrix (ECM) that maintain and support a healing environment through constructive remodeling, and are available in particle and sheet forms by prescription only.

"We are very satisfied with the results of this independent study on non-healing wounds. MatriStem has shown to be effective where other products fail," Rodney Bosley, ACell president & COO said. "Results like these have established ACell as a leader in Regenerative Medicine."

The study was independent in nature. No external sources of funding for this study were received by the authors or the medical facility where the patients received treatment. The authors had no conflicts of interest to declare.